Moreover, inhibition of canonical NF-κB activation through targeting BTK has been found to reduce CD4+ and CD8+ T cells within the microenvironment and dampen expression of chemo-attractants produced by tumor associated macrophages (71–73). This evidence concerns the gene CD4 and neoplasm.